Cobra Biomanufacturing will carry out downstream processing for a protein from the SARS virus for an undisclosed pharmaceutical company. The protein will be manufactured by the pharma partner and will be used in phase I trails.
Cobra
Thursday 28 February 2008
Cobra in SARS protein deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment